血清氯离子、白细胞介素-6联合凝血指标对重症急性胰腺炎严重程度的预测价值
该研究回顾性纳入郑州大学第一附属医院急诊外科2020年12月至2022年3月收治的132例急性胰腺炎(AP)患者,按分类标准分为重症急性胰腺炎(SAP)组63例与非SAP组69例。结果显示SAP组血清IL-6、D-二聚体、FDP水平及BISAP评分均显著高于非SAP组,血清Cl-水平显著低于非SAP组(均P<0.05)。多因素Logistic回归显示IL-6升高(OR=1.02)、D-二聚体升高(OR=1.21)、Cl-降低(OR=0.88)是SAP的危险因素(均P<0.05)。ROC分析显示四指标联合预测AP严重程度的AUC为0.89,灵敏度82.50%、特异度85.50%。作者认为联合检测较单一指标能更精确判断AP病情。
要点
- SAP组血清IL-6为62.73(21.54, 187.47)ng/L,高于非SAP组的8.22(4.13, 14.70)ng/L(P<0.05)。
- SAP组血清Cl-为97.90±4.86 mmol/L,低于非SAP组的101.73±4.32 mmol/L(P<0.05)。
- 多因素Logistic回归:IL-6升高OR=1.02(95%CI 1.01-1.04)、D-二聚体升高OR=1.21(95%CI 1.05-1.40)、Cl-降低OR=0.88(95%CI 0.79-0.98)为SAP危险因素(均P<0.05)。
- IL-6、Cl-、D-二聚体、FDP四联预测AP严重程度的AUC为0.89,灵敏度82.50%、特异度85.50%。
- SAP组BISAP评分为2.00(1.00, 3.00),高于非SAP组的1.00(0, 2.00)(P<0.05)。
适用人群与场景
- 2020年12月至2022年3月郑州大学第一附属医院急诊外科收治的AP患者,从292例中筛选出符合纳入标准的132例进行回顾性分析。
- 按分类标准分为SAP组63例与非SAP组69例。
诊断标准与关键阈值
- 依据分类标准将AP患者分为重症急性胰腺炎(SAP)组与非SAP组。
- 计算床旁急性胰腺炎严重程度指数(BISAP)评分。
研究设计与关键结果
- 研究类型为回顾性分析,纳入132例AP患者(SAP组63例、非SAP组69例),来自郑州大学第一附属医院急诊外科。
- SAP组血清IL-6为62.73(21.54, 187.47)ng/L vs 非SAP组8.22(4.13, 14.70)ng/L;D-二聚体为5.36(2.94, 8.25)mg/L vs 0.94(0.42, 2.21)mg/L;FDP为13.54(6.76, 22.45)mg/L vs 3.20(2.50, 6.10)mg/L;BISAP评分为2.00(1.00, 3.00)vs 1.00(0, 2.00),均P<0.05。
- SAP组血清Cl-为97.90±4.86 mmol/L,低于非SAP组的101.73±4.32 mmol/L(P<0.05)。
- 多因素Logistic回归显示IL-6升高(OR=1.02,95%CI 1.01-1.04)、D-二聚体升高(OR=1.21,95%CI 1.05-1.40)、Cl-降低(OR=0.88,95%CI 0.79-0.98)为SAP的危险因素(均P<0.05)。
- ROC曲线分析显示IL-6、Cl-、D-二聚体、FDP联合预测AP严重程度的AUC为0.89,灵敏度82.50%、特异度85.50%。
证据类型、等级与局限
- 证据类型为回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与单一指标相比,联合检测血清IL-6、Cl-、D-二聚体、FDP能更精确地判断AP病情。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the predictive value of combined detection of serum interleukin-6 (IL-6), chloride (Cl-), D-dimer and fibrin degradation products (FDP) for severity of acute pancreatitis (AP).
METHODS: From December 2020 to March 2022, 132 AP patients who met the criteria for inclusion were screened for retrospective analysis from 292 AP patients admitted in emergency surgery at the First Affiliated Hospital of Zhengzhou University and they were divided into severe acute pancreatitis (SAP) group and non-SAP group, with 63 in SAP group and 69 in non-SAP group, according to classification criteria. The data including lab results, abdominal doppler ultrasound and chest and abdominal CT, etc. The bedside index for severity in acute pancreatitis (BISAP) score was calculated. Multivariate Logistic regression analysis was carried out to find the risk factors for the severity of AP patients. The receiver operator characteristic curve (ROC) was drawn to judge the clinical predictive value of each factor.
RESULTS: A total of 132 AP patients were enrolled. The serum IL-6, D-dimer, FDP levels and the BISAP score in SAP group were significantly higher than those in non-SAP group [serum IL-6 (ng/L): 62.73 (21.54, 187.47) vs. 8.22 (4.13, 14.70), D-dimer (mg/L): 5.36 (2.94, 8.25) vs. 0.94 (0.42, 2.21), FDP (mg/L): 13.54 (6.76, 22.45) vs. 3.20 (2.50, 6.10), BISAP score: 2.00 (1.00, 3.00) vs. 1.00 (0, 2.00), all P < 0.05], while the serum Cl- level was significantly lower than that of non-SAP group (mmol/L: 97.90±4.86 vs. 101.73±4.32, P < 0.05). Multivariate Logistic regression analysis showed that increased levels of IL-6 [odds ratio (OR) = 1.02, 95% confidence interval (95%CI) was 1.01-1.04], D-dimer (OR = 1.21, 95%CI was 1.05-1.40) and decreased Cl- level (OR = 0.88, 95%CI was 0.79-0.98) were risk factors for SAP (all P < 0.05). The ROC curve analysis showed that the area under the ROC curve (AUC) of IL-6, Cl-, D-dimer and FDP combined to predict the severity of AP patients was larger (0.89), and the sensitivity (82.50%) and specificity (85.50%) were higher.
CONCLUSIONS: Compared with single index, the combined detection of serum IL-6, Cl-, D-dimer and FDP is more precise in determining the condition of AP.
参考来源
- Cui H, Mei C, Cui M, et al. [Predictive value of serum chlorine and interleukin-6 combined with coagulation indexes on severity of severe acute pancreatitis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36567587. doi:10.3760/cma.j.cn121430-20220916-00844
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。